Bates, M.D.. AMS agrees to market Gamma radiation and Knife therapy services business in Turkey to Euromedic AMERICAN SHARED HOSPITAL Providers , a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, declared today that it has entered into an agreement to market its Gamma Knife and radiation therapy services business in Turkey to Euromedic Cancer tumor Treatment Centers BV . The purchase is at the mercy of standard closing conditions, on June 10 and can be expected to close, 2014. Payment to AMS will maintain the form of cash, which predominantly will be used to lower debt associated with the Turkish procedures. Additionally, AMS is qualified to receive an earn-out based on future income from both Gamma Knife devices and one Image Guided Radiation Therapy unit AMS currently operates in Istanbul and Adana, Turkey.For the ANCOVA model, the group receiving 80 mg of atorvastatin plus SAR236553 was weighed against the group receiving 80 mg of atorvastatin plus placebo, and the 95 percent confidence interval of the difference was calculated. For secondary end or analyses points, P values have already been provided for descriptive reasons only and have not really been modified for multiple testing. Although formal comparisons with the combined group receiving 10 mg of atorvastatin plus SAR236553 weren’t planned, these were performed post hoc for descriptive reasons.